Content deleted Content added
Updating {{chembox}} (changes to verified and watched fields - added verified revid - updated 'CASNo_Ref', 'Verifiedfields', 'Watchedfields', 'verifiedrevid') per Chem/Drugbox validation (report [[Wikipedia_talk:WikiProject_Chemicals|e... |
|||
Line 1: | Line 1: | ||
{{chembox |
{{chembox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
|ImageFile=Allylglycine.png |
|ImageFile=Allylglycine.png |
||
|ImageSize=180px |
|ImageSize=180px |
||
Line 15: | Line 17: | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = WNNNWFKQCKFSDK-UHFFFAOYSA-N |
| StdInChIKey = WNNNWFKQCKFSDK-UHFFFAOYSA-N |
||
| CASNo_Ref = {{cascite|changed|??}} |
|||
| CASNo=7685-44-1 |
| CASNo=7685-44-1 |
||
| PubChem=14044 |
| PubChem=14044 |
Revision as of 18:59, 13 January 2014
Names | |
---|---|
IUPAC name
2-Aminopent-4-enoic acid
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.028.809 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C5H9NO2 | |
Molar mass | 115.13 g/mol |
Appearance | white crystalline powder |
Density | 1.098 g/mL |
Melting point | 265 °C (509 °F; 538 K) |
Boiling point | 231 °C (448 °F; 504 K) |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Irritant |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Allylglycine is a glycine derivative. It is an inhibitor of the enzyme glutamate decarboxylase.[1] Inhibition of glutamate decarboxylase blocks GABA biosynthesis, leading to lower levels of the neurotransmitter.[2] It is used to induce convulsions in animals in scientific studies.[citation needed]
References
- ^ Abshire VM, Hankins KD, Roehr KE, DiMicco JA (November 1988). "Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate". Neuropharmacology. 27 (11): 1171–7. doi:10.1016/0028-3908(88)90013-5. PMID 3205383.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Sajdyk T, Johnson P, Fitz S, Shekhar A (August 2008). "Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior". J. Psychopharmacol. (Oxford). 22 (6): 633–41. doi:10.1177/0269881107082902. PMID 18308797.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)